Redpoint Investment Management’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | $5.42M | Sell |
123,853
-18,061
| -13% | -$790K | 0.79% | 18 |
|
|
2022
Q2 | $7.44M | Hold |
141,914
| – | – | 0.88% | 14 |
|
|
2022
Q1 | $7.35M | Buy |
141,914
+12,238
| +9% | +$634K | 0.74% | 17 |
|
|
2021
Q4 | $7.66M | Sell |
129,676
-13,729
| -10% | -$811K | 0.61% | 26 |
|
|
2021
Q3 | $6.17M | Sell |
143,405
-1,747
| -1% | -$75.1K | 0.53% | 34 |
|
|
2021
Q2 | $5.68M | Buy |
145,152
+709
| +0.5% | +$27.8K | 0.46% | 40 |
|
|
2021
Q1 | $5.23M | Buy |
144,443
+1,074
| +0.7% | +$38.9K | 0.44% | 47 |
|
|
2020
Q4 | $5.28M | Buy |
143,369
+304
| +0.2% | +$11.2K | 0.54% | 37 |
|
|
2020
Q3 | $4.98M | Sell |
143,065
-191,982
| -57% | -$6.68M | 0.54% | 41 |
|
|
2020
Q2 | $10.4M | Sell |
335,047
-27,306
| -8% | -$847K | 0.57% | 33 |
|
|
2020
Q1 | $11.2M | Sell |
362,353
-23,237
| -6% | -$720K | 0.7% | 24 |
|
|
2019
Q4 | $14.3M | Sell |
385,590
-3,652
| -0.9% | -$136K | 0.7% | 26 |
|
|
2019
Q3 | $13.3M | Sell |
389,242
-37,910
| -9% | -$1.29M | 0.7% | 29 |
|
|
2019
Q2 | $17.6M | Sell |
427,152
-34,727
| -8% | -$1.43M | 0.93% | 14 |
|
|
2019
Q1 | $18.6M | Buy |
461,879
+13,153
| +3% | +$530K | 0.93% | 16 |
|
|
2018
Q4 | $18.6M | Buy |
448,726
+3,200
| +0.7% | +$133K | 1.08% | 10 |
|
|
2018
Q3 | $18.6M | Sell |
445,526
-25,404
| -5% | -$1.06M | 0.94% | 13 |
|
|
2018
Q2 | $16.2M | Sell |
470,930
-928
| -0.2% | -$31.9K | 0.88% | 19 |
|
|
2018
Q1 | $15.9M | Buy |
471,858
+3,178
| +0.7% | +$107K | 0.88% | 16 |
|
|
2017
Q4 | $16.1M | Buy |
+468,680
| New | +$16.1M | 0.89% | 18 |
|